Entity

Time filter

Source Type

New Orleans, LA, United States

Loyola University New Orleans is a private, co-educational and Jesuit university located in New Orleans, Louisiana, United States. Originally established as Loyola College in 1904, the institution was chartered as a university in 1912. It bears the name of the Jesuit patron, Saint Ignatius of Loyola. Loyola is one of 28 member institutions that make up the Association of Jesuit Colleges and Universities and, with its current enrollment of approximately 5000 students, is among the larger Jesuit universities in the southern United States. Loyola University New Orleans is ranked eleventh best institution among Southern regional universities offering masters and undergraduate degrees in the 2015 issue of the annual America's Best Colleges issue and guidebook published by U.S. News & World Report. The Princeton Review also features Loyola University New Orleans in the most recent editions of its annual book, The Best 371 Colleges. In the past, the school has been called Loyola of the South, Loyola New Orleans, Loyola University, New Orleans, and Loyola University of New Orleans. Wikipedia.


Walkenhorst W.F.,Loyola University New Orleans
Biochimica et Biophysica Acta - Biomembranes | Year: 2016

The increase in antibiotic resistant and multi-drug resistant bacterial infections has serious implications for the future of health care. The difficulty in finding both new microbial targets and new drugs against existing targets adds to the concern. The use of combination and adjuvant therapies are potential strategies to counter this threat. Antimicrobial peptides (AMPs) are a promising class of antibiotics (ABs), particularly for topical and surface applications. Efforts have been directed toward a number of strategies, including the use of conventional ABs combined with AMPs, and the use of potentiating agents to increase the performance of AMPs. This review focuses on combination strategies such as adjuvants and the manipulation of environmental variables to improve the efficacy of AMPs as potential therapeutic agents. This article is part of a Special Issue entitled: Antimicrobial peptides edited by Karl Lohner and Kai Hilpert. © 2016 Elsevier B.V. Source


Block W.,Loyola University New Orleans
Journal of Medicine and Philosophy | Year: 2010

The present paper attempts to forge a compromise between those who maintain that stem cell research is out-and-out murder of young helpless human beings and those who favor this practice. The compromise is predicated upon the libertarian theory of private property rights. Starting out with the premise that not only the fetus but even the fertilized egg is a human being, with all rights thereto, it offers a competition between those who fertilize eggs for research and those who wish to adopt them. If and only if the former win this competition will they be allowed to use these very young human beings for the purposes they have constructed them. This is justified on grounds of avoiding child abuse. © The Author 2010. Source


Biswas T.,Loyola University New Orleans | Okada N.,University of Alabama
Nuclear Physics B | Year: 2015

We take a few steps towards constructing a string-inspired nonlocal extension of the Standard Model. We start by illustrating how quantum loop calculations can be performed in nonlocal scalar field theory. In particular, we show the potential to address the hierarchy problem in the nonlocal framework. Next, we construct a nonlocal abelian gauge model and derive modifications of the gauge interaction vertex and field propagators. We apply the modifications to a toy version of the nonlocal Standard Model and investigate collider phenomenology. We find the lower bound on the scale of nonlocality from the 8 TeV LHC data to be 2.5-3 TeV. © 2015 Published by Elsevier B.V. Source


Block W.E.,Loyola University New Orleans
Journal of Medicine and Philosophy (United Kingdom) | Year: 2014

There is a new sheriff in town on the abortion question. It is called evictionism. It diverges, philosophically, from both the pro-life and the pro-choice positions. It assumes that the birth of a human being starts with the fertilized egg but claims that the unwanted baby is a trespasser that may be evicted in the gentlest manner possible. © 2014 The Author. Source


Ferguson L.A.,Loyola University New Orleans
Journal of Pediatric Health Care | Year: 2011

Society often rewards the beautiful, the smart, and the intelligent. The possibility that children with idiopathic short stature (ISS) will sustain psychological damage as a result of ridicule from their peers is a concern. The desire for children to become tall adults provides a difficult quandary for parents and caregivers. Growth hormone (GH) treatment in children requires subcutaneous injections six to seven times weekly. The cost of treating with GH can be more than $52,000, and many third-party payers do not cover the cost of GH treatment. Research to date would indicate that while the administration of GH may improve final adult height in children with ISS, children treated with GH will remain short when compared with peers. More research is needed to study whether the administration of GH is beneficial for children with ISS. This article will discuss ISS and the use of GH in children. © 2011 National Association of Pediatric Nurse Practitioners. Source

Discover hidden collaborations